Literature DB >> 26548540

Moving beyond evidence-based medicine: Incorporating patient values and preferences.

Aria Fallah1.   

Abstract

Entities:  

Year:  2015        PMID： 26548540     DOI： 10.1016/j.yebeh.2015.10.006

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN： 1525-5050            Impact factor:   2.937


× No keyword cloud information.
  5 in total

1.  Perceptions and preferences for long-acting injectable and implantable medications in comparison to short-acting medications for opioid use disorders.

Authors:  Elizabeth C Saunders; Sarah K Moore; Olivia Walsh; Stephen A Metcalf; Alan J Budney; Emily Scherer; Lisa A Marsch
Journal:  J Subst Abuse Treat       Date:  2020-01-21

2.  Survival in pediatric medulloblastoma: a population-based observational study to improve prognostication.

Authors:  Alexander G Weil; Anthony C Wang; Harrison J Westwick; George M Ibrahim; Rojine T Ariani; Louis Crevier; Sebastien Perreault; Tom Davidson; Chi-Hong Tseng; Aria Fallah
Journal:  J Neurooncol       Date:  2016-12-15       Impact factor: 4.130

3.  Integrating the Principles of Evidence Based Medicine and Evidence Based Public Health: Impact on the Quality of Patient Care and Hospital Readmission Rates in Jordan.

Authors:  Mohammad S Alyahya; Heba H Hijazi; Hussam A Alshraideh; Mohammad Aser Alsharman; Rabah Al Abdi; Heather Lea Harvey
Journal:  Int J Integr Care       Date:  2016-08-31       Impact factor: 5.120

4.  "It's way more than just writing a prescription": A qualitative study of preferences for integrated versus non-integrated treatment models among individuals with opioid use disorder.

Authors:  Elizabeth C Saunders; Sarah K Moore; Olivia Walsh; Stephen A Metcalf; Alan J Budney; Patricia Cavazos-Rehg; Emily Scherer; Lisa A Marsch
Journal:  Addict Sci Clin Pract       Date:  2021-01-27

5.  A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication.

Authors:  Adam Strzelczyk; Susanne Schubert-Bast
Journal:  CNS Drugs       Date:  2022-02-14       Impact factor: 5.749
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.